Pfizer and Takeda Receive $2.15 Billion Patent Infringement Settlement

Andrew Klips |

Pfizer (PFE) has settled for $2.15 billion with Teva Pharmaceuticals (TEVA) and Sun Pharmaceuticals for patent infringement damages on acid-reflux drug Protonix, according to the company’s website.

Israel’s Teva, the world’s largest generic drug maker, began selling a generic version of Protonix in 2007, but a court ruled in 2010 that Teva had infringed on Pfizer’s patent. Wednesday’s settlement finally marked the end of the 10-year legal battle and helped avoid a lengthy trial.

Pfizer’s executive vice president Amy W. Shulman announced on the company website, “We are pleased with today’s settlement, which recognizes the validity and value of innovation that led to Protonix.”

Pfizer also announced that it would receive 64 percent of the $2.15 billion settlement, while the remaining 36 percent will go to Japan’s Takeda Pharmaceutical Co., Pfizer’s partner on the drug. Teva is on the hook for $1.6 billion and the India-based Sun will pay $550 million.

Teva was well prepared for the legal hit, as the company set aside $2.07 billion to resolve the case according to CNBC. However, the India-based Sun only set aside $100 million for potential losses, and must now hand over five and a half times that amount.

Pfizer shares reacted positively the news, rising 0.40 percent to $28.53 despite a significant pullback in the broader market.

Meanwhile, Teva shares traded down 1.96 percent to $39.05 on Wednesday. The stock has been a perennial laggard and one of the worst performers in the entire healthcare industry over the last two years. Shares are down almost 20 percent, while shares of rivals Pfizer and Merck (MRK) have soared almost 40 percent during the same timeframe.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Symbol Name Price Change % Volume
BVXVW BiondVax Pharmaceuticals Ltd. Warrants 0.47 0.00 0.00 123
MRK Merck & Company Inc. (new) 61.95 1.20 1.98 15,180,457
PFE Pfizer Inc. 32.28 0.15 0.47 19,335,576
TEVA Teva Pharmaceutical Industries Limited American De 43.85 0.35 0.80 12,979,309


Emerging Growth

International Western Petroleum Inc

International Western Petroleum Inc is an exploration-stage oil and natural gas company. The Company is engaged in the acquisition, development, and exploration of crude oil and natural gas properties in…

Private Markets


Spotify is a online music service offering providing digital content from a range of record labels and artists. Users can browse through the interface by artist, album, genre, playlist, record…


Airbnb is a community marketplace for people to list, discover, and book unique accommodations around the world — online or from a mobile phone. Whether an apartment for a night,…